TrueTear in Sjogren's Disease Patients
common.study.values.description
“TrueTear in Sjogren's Disease Patients”
The purpose of this study is to evaluate acute tear production produced by the intranasal tear neurostimulator in participants with SjA?grens syndrome and aqueous tear deficiency. Our primary goal is to evaluate whether SjA?grens patients respond to this intervention and whether there is a baseline tear production level below which these patients do not respond.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Device - TrueTear Intranasal Tear Neurostimulator
This study will evaluate the immediate tear production resulting from use of intranasal tear neurostimulation in patients with Sjogren's disease
participant.views.study.view.additional
participant.views.study.view.scientific-title
Prospective Controlled Study of Intranasal Tear Neurostimulation for Sjogrens Patients With Dry Eye Disease
common.study.values.clinical-trial-id
NCT03719885
participant.views.study.view.id
axklre
